Skip to main content
. 2017 Feb 17;188(2):234–242. doi: 10.1111/cei.12924

Figure 3.

Figure 3

The mRNA expression of semaphorin5A (Sema5A) and ADAM metallopeptidase domain 17 (ADAM17) in peripheral blood mononuclear cells (PBMC) systemic lupus erythematosus (SLE) SLE patients. (a) There was no significant difference in Sema5A mRNA expression between SLE patients and healthy controls. (b) The ADAM17 mRNA level in peripheral blood mononuclear cells (PBMCs) was significantly higher in SLE patients than in healthy controls.